Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 May 27;94(11):5882-7.
doi: 10.1073/pnas.94.11.5882.

The second finger of Urbs1 is required for iron-mediated repression of sid1 in Ustilago maydis

Affiliations

The second finger of Urbs1 is required for iron-mediated repression of sid1 in Ustilago maydis

Z An et al. Proc Natl Acad Sci U S A. .

Abstract

The urbs1 gene encodes a transcriptional regulator of siderophore biosynthesis in Ustilago maydis. Biological and DNA-binding activities of the two putative zinc-finger motifs of Urbs1 were studied by analyzing mutants containing altered finger domains. The mutated urbs1 alleles from three previously described N'-methyl-N'-nitro-N-nitrosoguanidine (NTG) mutants were mapped and cloned by a gap-repair procedure. Sequence analyses revealed single amino acid substitutions in two of the NTG mutants. Both mutations (G-507 to D in urbs1-1 and P-491 to L in urbs1-3), which are located in the Urbs1 C-terminal finger domain, reduced DNA-binding activity by 10-fold and were sufficient to confer a urbs1-minus phenotype. The third NTG urbs1 mutant (urbs1-2) also contained a mutation in one of the conserved amino acids (P-518 to S) in the C-terminal finger domain, but this mutation alone was not sufficient to confer a urbs1-minus phenotype. A second frame shift mutation was identified in urbs1-2 and is necessary for the urbs1-minus phenotype. In an analysis of the function of the N-terminal finger of Urbs1, the conserved amino acid Arg-350 was mutated to leucine. A Urbs1 protein with this mutation complemented a urbs1 null mutant strain. By contrast, a similar mutation in the C-terminal domain abolished the ability of Urbs1 to regulate siderophore biosynthesis and greatly reduced its ability to bind target DNA.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) urbs1 locus of U. maydis. Horizontal arrow represents the urbs1 open reading frame (ORF). Restriction sites: A, AsuII; B, BamHI; BI, BglII; H, HindIII; P, PstI; S, StuI; X, XbaI. (B) Epitope-tagged urbs1 alleles. pAN15 contains the wild-type allele. pAN15–1, pAN15–2, and pAN15–3 contain the NTG-induced urbs1 mutations contained in the 2-kb StuI fragment from UMC002, UMC005, and UMC007, respectively. pAKR494L and pAKR350L contain single amino acid mutations introduced via site-directed mutagenesis.
Figure 2
Figure 2
Detection of epitope-tagged wild-type (pAN15) and mutant (pAN15–1, pAN15–2, and pAN15–3) Urbs1 by Western blotting. UMC015 is a urbs1 disruption mutant. pSC3 carries the wild-type urbs1 gene. pAN15 carries the urbs1-tag gene. pAN15–1, pAN15–2, and pAN15–3 carry the tagged mutant urbs1 alleles from UMC002 (urbs1–1), UMC005 (urbs1–2), and UMC007 (urbs1–3), respectively. Assay conditions are as previously described.
Figure 3
Figure 3
DNA-binding assay of the 0.3-kb DNA fragment with whole cell protein extracts of UMC015, UMC015/pSC3, UMC015/pAN15, UMC015/pAN15–1, UMC015/pAN15–2, and UMC015/pAN15–3. Strain UMC015 and various plasmids are described in Fig. 1 and in the text. Assay conditions are as previously described.
Figure 4
Figure 4
(A) DNA-binding assay of the 0.3-kb DNA fragment with whole cell protein extracts of UMC015, UMC015/pAN15, UMC015/pAKR350L, and UMC015/pAKR494L. Strain UMC015 is described in the text. pAKR350L and pAKR494L carry the Arg-350 to leucine mutation in the N-terminal finger domain and the analogous Arg-494 to leucine mutation in the C-terminal finger domain, respectively. Assay conditions are as previously described. (B) Detection of epitope-tagged wild-type (pAN15) and mutant (pAKR350L and pAKR494L) Urbs1 by Western blotting. Conditions are as in Fig. 2.

References

    1. Crichton R, Ward R J. Biochemistry. 1992;25:11255–11264. - PubMed
    1. DeSilva D M, Askwith C C, Kaplan J. Physiol Rev. 1996;76:31–47. - PubMed
    1. Guerinot M L. Annu Rev Microbiol. 1994;48:743–772. - PubMed
    1. Halliwell B, Gutteridge J M C. Biochem J. 1984;219:1–14. - PMC - PubMed
    1. Budde A D, Leong S A. Mycopathologia. 1989;108:125–133. - PubMed

Publication types

MeSH terms

Associated data